ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,986Medicare Part D Prescriptions Filled, Including Refills

Rank: 166 out of 780

$868K Total Retail Price of All Prescriptions

Rank: 102 out of 780

516 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 516 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

16% of this provider’s 516 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 11,154 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
WARFARIN SODIUM 512 443 1 24
AMLODIPINE BESYLATE 415 321 2 4
FUROSEMIDE 383 295 3 7
SIMVASTATIN 347 268 4 2
OMEPRAZOLE 337 284 5 3
HYDROCODONE-ACETAMINOPHEN 329 267 S3 6 1
NAMENDA 321 307 7 46
MIRTAZAPINE 302 280 8 58
DONEPEZIL HCL 291 287 9 31
HYDROCHLOROTHIAZIDE 263 160 10 10
LEVOTHYROXINE SODIUM 260 234 11 5
TRAMADOL HCL 250 173 12 15
POTASSIUM CHLORIDE 243 206 13 11
PANTOPRAZOLE SODIUM 222 155 14 25
GABAPENTIN 208 172 15 13
CITALOPRAM HBR 192 190 16 23
LISINOPRIL 188 151 17 6
BUSPIRONE HCL 184 140 18 125
METOPROLOL TARTRATE 174 118 19 19
CYCLOBENZAPRINE HCL 170 74 R 20 42
METFORMIN HCL 169 117 21 8
CLONIDINE HCL 166 108 22 28
LYRICA 149 92 23 52
LIDODERM 148 135 24 224
CARVEDILOL 135 109 25 14
PRAVASTATIN SODIUM 130 103 26 9
ESCITALOPRAM OXALATE 129 113 27 61
FLUTICASONE PROPIONATE 129 98 27 41
QUETIAPINE FUMARATE 124 123 29 81
ATENOLOL 120 87 30 21
EXELON 114 105 31 132
METOPROLOL SUCCINATE 111 103 32 20
LEVETIRACETAM 104 63 33 130
DIGOXIN 104 94 33 56
PLAVIX 103 86 35 45
CLOPIDOGREL 99 87 36 34
NAPROXEN 98 73 37 100
RISPERIDONE 97 97 38 98
HYDRALAZINE HCL 96 93 39 54
GLIPIZIDE 95 53 40 74
ATORVASTATIN CALCIUM 93 49 41 12
LANTUS 92 78 42 71
DIVALPROEX SODIUM 92 75 42 119
ZOLPIDEM TARTRATE 91 77 44 17
FAMOTIDINE 87 76 45 86
RANITIDINE HCL 79 71 46 39
CARBIDOPA-LEVODOPA 79 79 46 124
NOVOLOG 77 58 48 158
TRAZODONE HCL 76 65 49 35
DETROL LA 76 67 49 215
TAMSULOSIN HCL 73 69 51 36
LOSARTAN POTASSIUM 73 67 51 18
LISINOPRIL-HYDROCHLOROTHIAZIDE 71 63 53 26
PROAIR HFA 70 35 54 62
MEGESTROL ACETATE 68 63 R 55 161
PHENYTOIN SODIUM EXTENDED 67 43 56 128
NUEDEXTA 66 66 57 356
ENOXAPARIN SODIUM 64 58 58 370
OLANZAPINE 63 52 59 191
ALLOPURINOL 61 47 60 29
DILTIAZEM 24HR CD 59 59 61 138
SEROQUEL 58 56 62 172
PROMETHAZINE HCL 56 40 R 63 66
CYMBALTA 56 49 63 51
CIPROFLOXACIN HCL 55 46 65 49
OXYBUTYNIN CHLORIDE ER 55 51 65 169
NEXIUM 53 18 67 22
GLIPIZIDE ER 51 37 68 109
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 11, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.